Healthcare
Tuesday, September 6, 2016
BRIEF-Moody's says Danaher's A2 rating unaffected by planned acquisition of Cepheid
* Moody's: Danaher's A2 rating unaffected by planned
acquisition of Cepheid for $4 billion
Source text for Eikon:
Further company coverage:,
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment